Johnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare Conference

Rhea-AI Summary

Johnson & Johnson (JNJ) to participate in the 2024 RBC Capital Markets Global Healthcare Conference on May 15th, with Tim Schmid representing the company. The live webcast will be accessible on the company's website.

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) will participate in the 2024 RBC Capital Markets Global Healthcare Conference on Wednesday, May 15^th, at the InterContinental Barclay Hotel, New York. Tim Schmid, Executive Vice President, Worldwide Chairman, MedTech, will represent the Company in a session scheduled at 11:00 am (Eastern Time).

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48-hrs after the webcast.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240408576293/en/

Media contact:

media-relations@its.jnj.com

Investor contact:

investor-relations@its.jnj.com

Source: Johnson & Johnson

When will Johnson & Johnson participate in the 2024 RBC Capital Markets Global Healthcare Conference?

Johnson & Johnson will participate in the 2024 RBC Capital Markets Global Healthcare Conference on May 15th.

Who will represent Johnson & Johnson at the conference?

Tim Schmid, Executive Vice President, Worldwide Chairman, MedTech, will represent Johnson & Johnson at the conference.

Where can investors access the live webcast of the conference?

Investors can access the live webcast of the conference on Johnson & Johnson's website at www.investor.jnj.com.

When will the audio webcast replay be available?

The audio webcast replay will be available approximately 48 hours after the webcast.